BSEInsider Trading / SAST1d ago
Johnson Pharmacare Ltd
Pursuant to PIT (Regulation), 2015 the Trading window shall remain closed from 01st October, 2026 till 48 hours after the declaration of unaudited financial result for the quarter and Half -Year ended 30th September, 2026.
Johnson Pharmacare Ltd has announced the closure of its trading window from 1st October 2026 to 48 hours after the declaration of unaudited financial results for the quarter and half-year ended 30th September 2026, as per SEBI (Prohibition of Insider Trading) Regulations, 2015.
BSECompany UpdateResults14 Aug 2026
Johnson Pharmacare Ltd
Pursuant to regulation 47 of LODR, 2015 -Submission of extract of Newspaper Publication for the unaudited financial result for the quarter ended 30th June, 2026.
Johnson Pharmacare Ltd has submitted the extract of newspaper publication for unaudited financial results for the quarter ended 30th June, 2026, as per Regulation 47 of LODR, 2015.
BSECompany Update13 Aug 2026
Johnson Pharmacare Ltd
Undertaking for non - applicability of reg 32 of sebi (lodr) reg 2015
Johnson Pharmacare Ltd has submitted an undertaking stating that Regulation 32 of SEBI (LODR) Regulations, 2015 is not applicable to the company for the quarter ended on June 30th, 2026, as no public issue, rights issue, or preferential issue was made during this period.
BSEResultResults13 Aug 2026
Johnson Pharmacare Ltd
Submission of Un-Audited Financial Results for the Quarter ended on June 30th 2026 and along with Limited Review Report Thereon.
Johnson Pharmacare Ltd has submitted its un-audited financial results for the quarter ended June 30th, 2026, along with a limited review report. The results were approved by the Board of Directors on August 13th, 2026.
BSEBoard MeetingResults13 Aug 2026
Johnson Pharmacare Ltd
UN-AUDITED FINANCIAL RESULTS
The Board of Director have considered and approved the Un-Audited Financial Results along with Limited Review Report thereon for quarter ended on June 30th, ....
Johnson Pharmacare Ltd's board of directors has approved the company's unaudited financial results for the quarter ended June 30, 2026, along with a limited review report. The results were reviewed by the company's statutory auditor, VRSK & Associates, and found to be in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
BSECompany Update11 Aug 2026
Johnson Pharmacare Ltd
The Exchange and Investors are hereby informed that boards of directors of the company had accorded thier approval for shifting of Registered Office of the Company from Existing Address ....
Johnson Pharmacare Ltd has informed the exchange that its board of directors has approved the shifting of its registered office address from the existing address to a new address within the local limits.
BSEBoard MeetingResults8 Aug 2026
Johnson Pharmacare Ltd
Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve To consider and approve ....
Johnson Pharmacare Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/08/2026 to consider and approve the Un-Audited (Standalone) Financial Results for the Quarter ended on 30th June, 2026.